ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 6002 participants.
Also called NCT04609111
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 6,002 participants
- Registry
-
NCT04609111
-
- Other papers using this trial's data
- An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
- Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation
- Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation
- Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
- Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
- Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial
- Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT04609111. Randomized; no masking; primary purpose treatment. Start 2021-01-29 (actual); primary completion 2023-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
- Acronym
- STOPDAPT-3
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- No aspirin
- Intervention (Drug)
- 1-month DAPT
- Lead sponsor
- Kyoto University, Graduate School of Medicine
Record details
- Record id
cardio:ct-nct04609111- Content hash
30ad20ffb27772f44bb75328a4fc0ed09b4f44073b5c028245f50f205464e599